MTOR and neoplasm: Moreover, alterations in the constituent genes of the two complexes constituting mTOR, mTORC1, and mechanistic target of rapamycin complex 2 (mTORC2), also contribute to the activation of the PI3K/AKT/mTOR signaling pathway, influencing the growth of tumor cells.